Melatonin (MT) (N-acetyl-5-methoxytryptamine) is a lipophilic and hydrophilic indoleamine with various physiologic functions MT presents in all cells and tissues and distributes in all cell compartments. Liver is the only organ of circulating MT metabolism. The roles of MT in various liver pathologies have been extensively studied, and it is believed that oxidative stress (OS) and lipid peroxidation (LPO) are the key causing factors of almost all conditions compromising liver function, including nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), diabetes, liver fibrosis and cirrhosis. MT improves energy production and reduces apoptosis OS and LPO in liver. MT protects liver against OS through multiple ways: inhibition of inflammatory cytokines, direct scavenge of free radicals, stimulation of antioxidant enzymes, decrease of mitochondrial electron leakage and synergistic function with other classical antioxidants.
INTRODUCTION

Melatonin and liver function
Melatonin (MT) (N-acetyl-5-methoxytryptamine) is a derivative of tryptophan through the serotonin pathway, and synthesized or present in variety of organs, such as pineal gland and gastrointestinal tract [1] [2] [3] . MT is a highly lipophilic and quite hydrophilic indoleamine product. MT is capable of interacting with lipid bilayers, crossing biological membranes and reaching all cellular compartments due to its high lipophilicity and rather small size 1, 4 . MT is serves as an autacoid factor with amphiphilicity and restricted toxicity even at high concentrations of administration. MT has the maximum secretion levels during the dark period of light/dark cycle, and the diurnal fluctuation of this hormone is reflected in its plasma level 5, 6 . MT initially found to control circadian, and has functional interactions with the circadian system and the neuroendocrine axis. Besides its multi-faceted free radical scavenging function, MT acts as antioxidant, gene regulator, immunomodulator, anti-apoptotic, anti-inflammatory, anti-gonadotropic, cytoprotective and oncostatic agent as well as a thermoregulator hormone 2, 6 . Target cells have membrane receptors for MT. Circadian control and antioxidant functions of this hormone are applied in a receptor-mediated manner. There are three receptors for MT: MT1 and MT2, which control various processes including cell proliferation, arterial vasoconstriction and metabolic functions, and also MT3, probably involves in cellular redox status regulation 1, 7, 8 . By using 2-125 1-iodomelatonin ( 125 1-aMT), cell nuclei proteins were identified to be in association with MT; 2-125 1-aMT has the high affinity in binding mouse hepatocyte membrane preparations. Nucleus binding sites may be a physiological MT receptor and the target for intracellular function of MT 2, 7 . The MT receptor type on mouse hepatocyte is of MT1 subclass, specifically MT1b. Local secretion of MT seems to modulate the action of gastrointestinal system, including liver, and that MT probably acts as a mediator in inter-organ communication between liver and gut 4, 9, 10 . Liver is one of the organs in the body for having high activities of antioxidant enzymes, and it is the solely organ in metabolism of circulating MT that by in turn regulates liver metabolism of carbohydrates and lipids. MT preserves glycogen stores, improves liver fatty changes, modulates liver concentrations of glucagon and insulin receptors, attenuates plasma cholesterol levels, induces gap junction expression and inhibits hepatocyte proliferation; inhibition of hepatocyte proliferation is to protect these cells against oxidative stress (OS) 2, 8, 11 . MT metabolites still have antioxidant activity, as 6-hydroxymelatonin sulfate scavenges free radicals. MT concentration in gastrointestinal tract is several hundred times more than its level in pineal gland 2, 10, 12 . MT has the highest concentration in the hepatobiliary system, namely liver, portal circulation and bile, where its level in bile is 1000-fold higher than blood levels during daytime and the concentration of MT in bile is 6 times higher than the concentration in tissue 5, 7, 12 .
MT distribution and metabolism in liver
MT has the significant higher content in the gut than in the pineal gland. MT has the nocturnal pattern of secretion over 8 h, and its pharmacological doses have no significant side effects, as 1200 mg/kg of MT has been used in human subjects without sings of toxicit ( 8, 11, 13 . Levels of MT are associated with various disorders and metabolic disturbances. MT has the highest level in serum. Serum MT concentrations are reduced by continuous light exposure 11, 14 . Serum levels of MT in mice oscillate from 160 pm per day to 1800 pm per night, which represents about 32-360 pg/ ml. In human plasma levels of MT during the night is exceeded 55 pg/ml, and in the morning hours is in the range of 20 pg/ml. Daily production of normal MT in human, male subjects, is 28.8 µg, and daily excretion of MT from the bile into the intestinal tract in human subjects is about 51 ng 3, 12, 15 . Increased systemic levels of MT has been documented following tryptophan administration in rats, pigs and cheeks, and increased plasma levels of MT has been attested following food restriction in human subjects. In humans total serum antioxidative capability correlates well with serum MT levels 2, 13 . In human the peak MT serum level after administration of 2 mg of MT is around 1-2 hours and after administration of 80 mg it rose from 350 to 1000 times over its concentration during night-time. Dietary MT results in a notable increase in MT levels, and has the greatest effects in middle-aged mice (1). MT is metabolically degraded at the site of production, and circulating MT in metabolically degraded in liver (2) . When oxidized, MT is not easily reduced and is not implicated in regenerating processes which may give rise to toxic recycling and free radicals formation (3). Instead, MT, upon oxidation, converts to antioxidant compounds, such as N 1 -acetyl-5-methoxykynuramine, N 1 -acetyl-N 2 -formyl-5-methoxy-kynuramine (AFMK) and cyclic 3-hydroxymelatonin (4). Cytochrome c, reactive oxygen species (ROS) and myeloperoxidase (MPO) could mediate MT oxidation to AFMK; degradation of AFMK to N 1 -acetyl-5-methoxykynuramine (AMK) is carried out by both arylamine formamidase and catalase (CAT) (2). Semak et al indicated that microsomal cytochrome P450 s are involved in conversion of MT into O-demethylation and hydroxylation at positions 2 and 6 as well as AFMK, and mitochondrial cytochrome P450 s are involved in conversion of MT into 2-hydroxymelatonin, Nacetylserotonin, AFMK, 6-hydroxymelatonin. They also showed that, in comparison with microsomal enzymes, mitochondrial cytochrome P450s have higher affinity for MT O-demethylation and 6-hydroxylation 2 . 6-hydroxylation is mainly mediated by cytochrome P4501A2 (CYP1A2), a high-affinity enzyme for MT metabolism in human liver microsome 5 .
Role of MT in energy production at liver Adequate maintenance of Adenosine triphosphate (ATP) levels is crucial for the liver cells viability, and its depletion causes membrane permeability derangement contributing to irreversible cell injury 6 . The depletion of ATP during ischemia leads to a loss of the transmembrane potential of mitochondria which is associated with overload of Ca 2+ and the following mitochondrial permeability transition (MPT) pore opening. Then overload of ions and hyperosmotic effect cause rapid swelling and rupture of mitochondria; as a result, cytochrome c, at the intermembrane space, releases into the cytosol and activates caspase 9 which in turn activates caspase 3 and the subsequent DNA fragmentation 7 . Release of cytochrome c may also due to production of NO triggered by increased Ca 2+ levels. Furthermore, ONOO-and possibly NO inhibit respiration through suppression of aconitase, a component of the Krebs cycle, in both mitochondria and cytosol 8 . Mitochondria are organelles in which high concentrations of MT seem to accumulate 9, 10 . Concentration of MT in the mitochondria is 100 times higher than in the blood 2 . MT (10 mg/kg BW) improves hepatic injury metabolism by reduction of the rate of mitochondrial energy transfer suppression and restoration to near normal of mitochondrial structure 11 . MT (1 nM) increases the activity of oxidative phosphorylation and complexes I & IV in rat liver mitochondria resulting in production of ATP 12 . The capability of MT to donate and accept electrons causes improvement of respiratory chain activity and increase of electron flow 6, 13 . MT could also detoxify electron-deficient ROS through its electron donation ability. Furthermore, MT reduces electron leakage and free radicals generation via potentiation of mitochondrial electron transport chain efficiency 9 . This efficiency is provided through stabilization of mitochondrial inner membranes by MT 14 . Glutamate dehydrogenase (GDH) activity is a marker of the integrity of mitochondrial membrane. Administration of MT (10 mg/kg) 15 min before ischemia and immediately before reperfusion increases the activity of GDH 7 .
Prevention of OS and LPO in liver by MT
OS is the consequence of redux balance disruption 10 between antioxidant and pro-oxidant species leading to oxidative damage of cellular macromolecules 15 and is the causing factor of aging 10 . These pro-oxidants are collectively known as ROS 15 . Approximately, 1-2% of the consumed oxygen by the organism at physiological level is converted to ROS 4 , and under normal conditions, antioxidant defense systems keep ROS at physiologically optimal levels 16 . Different types of ROS are considered as important mediators in various models of tissue injury 17 , such as toxic reactions, inflammation and ischemic processes 18 . The excessive production of ROS results in oxidative destruction to the deoxyribonucleic acid (DNA), proteins, and lipids. ROS can act with the nucleic acids attacking the nitrogenous bases and the sugar phosphate backbone and can elicit single-and double-stranded DNA breaks. ROS also attack structural and enzymatic proteins by the oxidation of residual amino acids, prosthetic groups, formation of cross links, protein aggregates, and proteolysis. The inactivation of the key proteins can lead to the serious consequences in the vital metabolic pathways. Lipid peroxidation (autooxidation) is a process of oxidation of polyunsaturated fatty acids due to the presence of several double bonds in their structure and it involves production of peroxides (chemical compounds in which two oxygen atoms are linked together by a single covalent bond), ROS, and other reactive organic free radicals 19 . In fatty liver, the predominant pro-oxidants are superoxide anion (O 2
•-) radical, singlet oxygen, ; ROS are involved in damaging various essential biological molecules including membrane lipids, DNA and cellular proteins 3 . ROS are derived from mitochondrial, microsomal and other hepatocellular pro-oxidant pathways in the critical reduction of antioxidant defenses 15 .
A major source of ROS is from the mitochondrial electron transport chain. ROS may be produced by other mechanisms. Radical scavenging function of MT exerts at both pharmacological and physiological concentrations and in vitro and in vivo 6 . MT exerts free radical scavenging by having acetyl group on the side chain and methoxyl group at the position five 20 . MT scavenges reactive nitrogen, reactive oxygen species (ROS) 15 , nitric oxide (NO) and singlet oxygen as well as is able to repair oxidatively damaged membrane lipids and cytosolic proteins 21 .
MT is also able to decrease oxygen consumption in liver mitochondria, which results in less ROS production 22 . ROS production resulting in oxidative damage increases intracellular Ca 2+ levels 23 . Ca 2+ then enters the nucleus to activate nucleases which cause breaks in DNA strands which to inhibited influx of Ca 2+ in cells via MT 23 . NF-kB activation, protein carbonyls and TBARS are OS markers 24 . NF-kB signaling activation is central to the inflammatory response pathophysiology 9 . NF-kB regulates various inflammatory genes including iNOS, IL-6, tumor necrosis factor-α (TNF-α) and IL-1β (9) . Although IL-1 does not induce liver damage, it could stimulate inflammatory cells to produce more TNF-α, IL-6 and IL-8 cytokines 21 . Liver is one of the organs vulnerable to the attack of pro-inflammatory cytokines 25 . Liver cells that produce proinflammatory cytokines are Kupffer cells, HSCs, BECs and endothelial sinusoid cells 25 . Kupffer cells play key roles in phagocytosis, immunomodulation and biochemical attack. These cells are activated by damaged hepatocytes, infiltrating inflammatory cells and toxic metabolic agents 21 . NF-kB is inhibits by Nuclear erythroid 2-related factor 2 (Nrf2) 9 . Nrf2 is a chief transcription factor involves in regulation of cellular antioxidative response against ROS. By binding to antioxidant response (ARE), upon cell stimulation, Nrf2 causes upregulation of antioxidant enzymes, and decreases sensitivity of the cells to OS 9, 24 . ARE sequence exists in the promoter region of most of the antioxidant enzymes encoding genes. . MT has immunomodulatory action, and by inhibition of nuclear translocation of NF-kB and its further binding to DNA may take part in the decrease of pro-inflammatory cytokines and adhesion molecules 24 ( Figure 1 ) . MT also increases the nuclear expression of Nrf2 9 and alters redox balance through increase of GSH levels and scavenge of ROS 26 . Wang et al. showed that MT has no direct effect on suppression of Kupffer cells 21 . Cell response against oxidative effects conveys through production of heat shock proteins (HSP), metallothionein 27 and antioxidant enzymes 3 . HSPs are molecular chaperons with key roles in the cell protection against OS toxic effects. MT is a cytosolic protein enriched in cysteine which acts as a potent ROS scavenger, and protects the cells against highly reactive compounds; in defense mechanisms to toxicity, MT is regarded as a cellular detoxification mediator of metals 27 . SOD and CAT are important antioxidant enzymes and have key defensive roles against free radicals 3 so that cooperative action of intracellular SOD, CAT and GPx is involved in liver detoxification of ROS 4 . Other antioxidant enzymes are reduced GSH, GPx 13 , glutathione reductase/ GRx, glucose 6-phosphate dehydrogenase, γ-glutamylcysteine synthase 4 . Glutathione peroxidase (GPx), as the most abundant peroxidase 28 , is an antioxidant enzyme involving in metabolism of potentially damaging molecules into non-toxic products 11 . Reduced GSH along with GPx are served as the main antioxidant protection of mitochondria, the organelle with lack of CAT for protection; mitochondria obtain GSH from cytosol. Chemical-induced oxidative liver injury showed depletion of GSH in mitochondria, rather than cytosol, for irreversible cellular damage development, therefore, mitochondrial GSH homeostasis is crucial for defending mitochondria and thus the whole cell against oxidative damage 13 . GSH content is an index for the cellular redox state 7 in which oxidized and reduced GSH ratio (GSSG/ GSH) is a sensitive cellular redox state indicator 16 . GSH plays a main role in the regulation of intracellular ROS 26 . GPx and CAT reduce the levels of hydrogen peroxide (H 2 O 2 ) 28 . GPx also reduces lipid peroxide, and it is important in LPO prevention and maintenance of the function and structure of biological membranes 15 . MT scavenges H 2 O 2 , thereby preventing the consumption of the GSH pool within mitochondria and the subsequent mitochondrial damage 29 . MT protects mitochondria from oxidative injury through decrease of excess Krebs' cycle, thereby restricts overstimulation of cellular respiration 22 . MT is also well-known to regulate and/or maintain the intracellular GSH concentration 10 and promotes GSSG to GSH conversion 30 . It has also been reported by Albarran et al. that there is a presumable relation between the MT rhythm with night time increase of SOD activity and blood levels of antioxidants 31 . However, depending upon the incubation time and concentration, MT could exert both antioxidant and pro-oxidant features; to explain, using MT at concentrations of 0.1-10 µm in the human liver cell line (HepG2) for 24 h shows antioxidant properties through increase of GSH level, which associated with cell viability improvement.
CONCLUSION
OS is an inducer of hepatocyte apoptosis, which works through intrinsic apoptosis pathway. OS and LPO potentially increases mitochondrial membrane permeability resulting in mitochondrial integrity loss and further cytochrome c release into cytoplasm; then, cytochrome c joins Apaf-1 which in turn polymerizes into apoptosome. Apoptosis can promote by ROS generation increment or endogenous antioxidant depletion. Liver mitochondria of mice showed age-related reduction in activities of complex I and IV, leading to excessive free radical generation and less effective mitochondrial defense against oxidative damage. Melatonin normalizes cytochrome c content in both cytosol and mitochondria. Melatonin also increases bcl2 antiapoptotic levels and decreases Bax antiapoptotic levels. The Bcl2 family is a key regulator of the intrinsic apoptosis pathway, which includes both antiapoptotic (bcl2 or bcl-xL) and proapoptotic (Bax) proteins. Melatonin is the antagonist of the apoptosis intrinsic pathway by alteration of Bax/bcl2 levels mostly through its radical scavenging function. Furthermore, melatonin-reperfused livers increase the area of ROS-positive hepatocytes; interestingly, this increase of ROS production did not augment OS to the liver parenchyma; instead, it was in agreement with the melatonin increase of bile production and ATP levels. OS induction, antioxidant status depletion and mitochondrial dysfunction are the relevant features in liver diseases. Moreover, Nrf2 that is a chief transcription factor involves in regulation of cellular antioxidative response against ROS causes upregulation of antioxidant enzymes, and decreases sensitivity of the cells to OS.
